Our most advanced system yet.
Preorder nowFor people who take multiple daily injections
Learn more Why InPen™ Get started with InPen™ Smart MDI CliniciansInjection port that lets you take your medication without having to puncture your skin for each shot
Learn more 30 day evaluation program Watch videoConverts data from your device into easy to understand insights about your sugar levels
Learn more Create an account For customers Login CareLink™ software support User guides and manuals FAQsThe following media kits are made available to provide reporters with background information on the range of Medtronic diabetes therapies and the conditions they treat.
Information about the MiniMed™ 780G system which is the first system with meal detection technology* that provides automatic adjustments and corrections† to sugar levels every 5 minutes§.
Information about the MiniMed™ 770G system which features smartphone connectivity and an expanded age indication down to the age of 2 years old.
Information about the InPen™ smart insulin pen system.
Information about the MiniMed™ 670G system, the world’s first hybrid closed loop system for individuals with type 1 diabetes.
Information about the Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart standalone CGM system to help people with diabetes using multiple daily injections (MDI) stay ahead of high and low glucose events.^
Information about Medtronic insulin pump therapy, continuous glucose monitoring and therapy management software.
References
*Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
† Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
§ Refers to SmartGuard™ feature. Individual results may vary.
‡ Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.
^ Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ™ insights that can inform users of clinically relevant glucose patterns.